Aptose生物科学 APTO 深 沪
等待开盘 02-05 09:30:00 美东时间
1.71
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 1.71
- 总市值 436.46万
- 52周最高 42.00
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.35
- 委 比 0.00%
- 总股本 255.24万
- 历史最高 5032.80
- 量 比 0
- 振 幅 0.00%
- 历史最低 3.30
- 每 手 1
- 风险率 1.08%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Aptose Reschedules Special Meeting on Hanmi Acquisition Plan
Aptose Biosciences ( ($TSE:APS) ) has issued an announcement. On December 19, 2...
2025-12-20 06:52
Aptose Biosciences Unveils Promising AML Therapy Data
The latest update is out from Aptose Biosciences ( ($TSE:APS) ). On December 6,...
2025-12-08 20:50
Aptose Biosciences GAAP EPS of -$2.01
Aptose Biosciences press release (OTC:APTOF): Q3 GAAP EPS of -$2.01. Total cash, cash equivalents and restricted cash equivalents as of September 30, 2025 were $1.6 million. The Company does not have ...
2025-11-14 14:11
Aptose Biosciences Q3 EPS $(2.01) Misses $(1.95) Estimate
Aptose Biosciences (TSX:APS) reported quarterly losses of $(2.01) per share which missed the analyst consensus estimate of $(1.95) by 3.08 percent. This is a 81.89 percent increase over losses of $(11.10) per share from
2025-11-14 06:21
Aptose Biosciences’ TUSCANY Study Highlighted at ASH 2025
Aptose Biosciences ( ($TSE:APS) ) just unveiled an update. On November 3, 2025,...
2025-11-03 22:52
Aptose Secures $11.9M Loan for AML Therapy Development
The latest update is out from Aptose Biosciences ( ($TSE:APS) ). Aptose Bioscie...
2025-09-22 20:14
Aptorum Group and DiamiR Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Aptorum Group and DiamiR Biosciences announced a joint presentation at the H.C. Wainwright conference on September 10, 2025. DiamiR’s CEO, Alidad Mireskandari, will deliver the presentation. The companies previously entered into a definitive agreement for an all-stock merger, under which DiamiR will become a wholly-owned subsidiary of Aptorum, subject to shareholder approval and customary closing conditions. The merger is expected to close in the...
2025-09-05 12:00
Aptose Biosciences Announces Executive Retention Awards
Aptose Biosciences ( ($TSE:APS) ) just unveiled an announcement. On August 19, ...
2025-08-28 05:30
Aptose Biosciences Secures Funding for Drug Development
Aptose Biosciences ( ($TSE:APS) ) has issued an update. On August 22, 2025, Apt...
2025-08-26 05:31
Aptose Biosciences Appoints New Independent Auditor
The latest announcement is out from Aptose Biosciences ( ($TSE:APS) ). On Augus...
2025-08-23 05:30
